Dr. Don Benson discusses the benefits of participating in a clinical trial image

Dr. Don Benson discusses the benefits of participating in a clinical trial

Posted on: Jul 19, 2013
Play Episode
Also available on
Overview

Dr. Don Benson, MD, PhD, The James Comprehensive Cancer Center, The Ohio State University
Interview Date: July 19, 2013

On this week's show, we learned that less than 5% of myeloma patients participate in clinical trials.  According to the American Cancer Society, if 10% of patients participated in clinical trials, we could reduce trial times from 3-5 years to 1 year, tripling the speed of research. This week's Myeloma Specialist, Dr. Don Benson of The James Cancer Center at The Ohio State University, does a deep dive to help us understand the ins and outs of medical trials. Dr. Benson provides a solid foundation for understanding clinical trials, answers patients' common questions and addresses the unfounded fears of being a "guinea pig" or getting a placebo in a trial.  He discusses how trials are funded, describes who is funding the most out-of-the-box, innovative ideas and explains why you may actually get better, more attentive care being part of a trial.

On this episode
Healthtree contact Jennifer Ahlstrom

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Transcript

Related Content